Armin Schultz
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
-
- Hormonal Regulation and Hypertension 2
- Co-authors
- Martin Wehling (8 shared papers)Ralf Lösel (5 shared papers)Martin Feuring (4 shared papers)Hanns-Christian Tillmann (1 shared paper)K Rossol-Haseroth (1 shared paper)Elisabeth Falkenstein (1 shared paper)Wolfgang Timmer (2 shared papers)Christina Schlecker (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (3 papers)Nature (2 papers)The Journal of Clinical Pharmacology (2 papers)Molecular and Cellular Endocrinology (1 paper)SpringerPlus (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Armin Schultz
27 papers receiving 3k citations
Armin Schultz's Hit Papers
Peers
Comparison fields: 5 of 107
- Infectious Diseases 1.6k
- Immunology 255
- Molecular Biology 472
- Genetics 216
- Dermatology 58
Countries citing papers authored by Armin Schultz
This map shows the geographic impact of Armin Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Schultz more than expected).
Fields of papers citing papers by Armin Schultz
This network shows the impact of papers produced by Armin Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Schultz. The network helps show where Armin Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Armin Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses Hit paper breakdown → | 2020 | 1585 |
| 2 | BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans Hit paper breakdown → | 2021 | 738 |
| 3 | 2003 | 484 | |
| 4 | 2018 | 28 | |
| 5 | 2014 | 27 | |
| 6 | 2003 | 25 | |
| 7 | 2018 | 22 | |
| 8 | 2005 | 20 | |
| 9 | 2004 | 19 | |
| 10 | 2022 | 18 | |
| 11 | 1987 | 16 | |
| 12 | 2003 | 16 | |
| 13 | 2011 | 14 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2007 | 8 | |
| 18 | 2006 | 7 | |
| 19 | 2014 | 7 | |
| 20 | 2025 | 7 |
About Armin Schultz
Armin Schultz is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Hepatology and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Estrogen and related hormone effects (3 papers), Nausea and vomiting management (2 papers), Hepatitis C virus research (2 papers), Hormonal Regulation and Hypertension (2 papers), Pharmaceutical studies and practices (2 papers), Statistical Methods in Clinical Trials (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (1.6k citations), Immunology (255 citations), Molecular Biology (472 citations), Genetics (216 citations) and Dermatology (58 citations). Armin Schultz has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Martin Wehling, Ralf Lösel, Martin Feuring, Hanns-Christian Tillmann, K Rossol-Haseroth, Elisabeth Falkenstein, Wolfgang Timmer, Christina Schlecker, Norbert Koch and Sybille Baumann. Their work appears in journals such as British Journal of Clinical Pharmacology, Nature, The Journal of Clinical Pharmacology, Molecular and Cellular Endocrinology and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.